EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system

Bruno Grassi, Ana Maria Gómez, Luis Eduardo Calliari, Denise Franco, Marcela Raggio, Francisca Riera, Matias Castro, Jennifer McVean, Tim van den Heuvel iD, Arcelia Arrieta, Javier Castañeda, Ohad Cohen

Diabetes, Obesity and Metabolism · 2023-06 · 25 (6) · 1688-1697

DOI: 10.1111/dom.15023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 13.03.2023. Verfasst von Bruno Grassi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

We studied real‐world performance of MiniMed (MM) 780G system users from Argentina, Brazil, Colombia and Chile (geographical analysis), and the effect of each technology iteration of the MM system on glycaemic control (technology iteration analysis). Materials and Methods CareLink data from August 2020 to September 2022 were extracted. Endpoints included continuous glucose monitoring metrics. For the geographical analysis, aggregated endpoints for MM780G system users were calculated. For the technology iteration analysis, MM780G system user outcomes were compared with outcomes when the same individuals were still using the MM640G or MM670G system.

Results

On average, 1025 MM780G system users from the geographical analysis were followed for 136 (SD 135) days, spent 91.5 (14.3)% in advanced hybrid closed loop, showed a glucose management indicator (GMI) of 6.7 (0.3)%, a time in range between 70 and 180 mg/dl (TIR) of 76.5 (9.0)%, and a time below range 70 mg/dl (TBR) of 2.7 (2.1)%. The percentage of users reaching targets of GMI 70% and TBR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDiabetes Mellitus, Type 1HumansHypoglycemic AgentsBlood GlucoseLatin AmericaBlood Glucose Self-MonitoringGlycemic ControlInsulin Infusion SystemsGlucoseInsulin, Regular, HumanTechnology

Stichwörter der Autor:innen

continuous glucose monitoringhealth economicsinsulin pump therapyreal-world evidencetype 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseGlucoseInsulin, Regular, Human

Autor:innen und Institutionen

  • Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Hospital Universitario de San Ignacio, Bogotá, Colombia.
  • Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • CPCLIN/DASA Clinical Research Centre, São Paulo, Brazil.
  • Hospital Universitario Austral, Buenos Aires, Argentina.

ORCID-Profile: Tim van den Heuvel

Zitieren

APA

Grassi, B., Gómez, A. M., Calliari, L. E., Franco, D., Raggio, M., Riera, F., Castro, M., McVean, J., van den Heuvel, T., Arrieta, A., Castañeda, J., & Cohen, O. (2023). Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes, Obesity and Metabolism, 25(6), 1688-1697. https://doi.org/10.1111/dom.15023

Vancouver

Grassi B, Gómez AM, Calliari LE, Franco D, Raggio M, Riera F, et al. Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes, Obesity and Metabolism. 2023;25(6):1688-1697. doi:10.1111/dom.15023

BibTeX
@article{Grassi2023,
  author = {Grassi, Bruno and Gómez, Ana Maria and Calliari, Luis Eduardo and Franco, Denise and Raggio, Marcela and Riera, Francisca and Castro, Matias and McVean, Jennifer and van den Heuvel, Tim and Arrieta, Arcelia and Castañeda, Javier and Cohen, Ohad},
  title = {Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  volume = {25},
  number = {6},
  pages = {1688--1697},
  doi = {10.1111/dom.15023}
}
Kostenlos starten →